January 17, 2025 · Form 4 insider transaction
Rasbach Kyle bought 245,250 shares of Lexeo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
25% of the shares underlying the option vest and become exercisable on December 18, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.